Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

5.800 -0.160 (-2.68%)
Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 167,929
Open 5.970
Bid (Size) 5.800 (1)
Ask (Size) 6.000 (6)
Prev. Close 5.960
Today's Range 5.750 - 6.100
52wk Range 3.510 - 16.95
Shares Outstanding 114,010,448
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Karyopharm Therapeutics Earnings Preview
 
Via Benzinga
This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga

Performance

YTD
-52.4%
-52.4%
1 Month
-6.6%
-6.6%
3 Month
+47.6%
+47.6%
6 Month
-21.2%
-21.2%
1 Year
-60.9%
-60.9%

More News

Read More
Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026
Via Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
Earnings Outlook For Karyopharm Therapeutics
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
Earnings Scheduled For February 19, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results
Via Benzinga
Earnings Scheduled For August 11, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What's going on in today's session
Via Chartmill
Here are the top movers in Wednesday's session.
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
Via Chartmill
Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
The current price of Karyopharm Therapeutics Inc. - Common Stock is 5.800
When was Karyopharm Therapeutics Inc. - Common Stock last traded?
The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 10/31/25 04:15 PM ET
What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 661.26M
How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
Karyopharm Therapeutics Inc. - Common Stock has 661M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.